scispace - formally typeset
A

A. Goldhirsch

Researcher at European Institute of Oncology

Publications -  29
Citations -  14569

A. Goldhirsch is an academic researcher from European Institute of Oncology. The author has contributed to research in topics: Breast cancer & Adjuvant therapy. The author has an hindex of 20, co-authored 29 publications receiving 14021 citations.

Papers
More filters
Journal ArticleDOI

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

O. Abe, +412 more
- 14 May 2005 - 
TL;DR: The 10-year and 15-year effects of various systemic adjuvant therapies on breast cancer recurrence and survival are reported and it is found that the cumulative reduction in mortality is more than twice as big at 15 years as at 5 years after diagnosis.
Journal Article

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, +226 more
- 18 Sep 1998 - 
TL;DR: The age-specific benefits of polychemotherapy appeared to be largely irrespective of menopausal status at presentation, oestrogen receptor status of the primary tumour, and of whether adjuvant tamoxifen had been given.
Journal ArticleDOI

Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005

TL;DR: The ninth St Gallen (Switzerland) expert consensus meeting in January 2005 made a fundamental change in the algorithm for selection of adjuvant systemic therapy for early breast cancer, reaffirming that the first consideration was endocrine responsiveness.